MY148518A - Crystalline parecoxib sodium - Google Patents
Crystalline parecoxib sodiumInfo
- Publication number
- MY148518A MY148518A MYPI20030900A MYPI20030900A MY148518A MY 148518 A MY148518 A MY 148518A MY PI20030900 A MYPI20030900 A MY PI20030900A MY PI20030900 A MYPI20030900 A MY PI20030900A MY 148518 A MY148518 A MY 148518A
- Authority
- MY
- Malaysia
- Prior art keywords
- parecoxib sodium
- anhydrous
- nonsolvated
- drug substance
- crystal forms
- Prior art date
Links
- 229960003925 parecoxib sodium Drugs 0.000 title abstract 4
- ICJGKYTXBRDUMV-UHFFFAOYSA-N trichloro(6-trichlorosilylhexyl)silane Chemical compound Cl[Si](Cl)(Cl)CCCCCC[Si](Cl)(Cl)Cl ICJGKYTXBRDUMV-UHFFFAOYSA-N 0.000 title abstract 4
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 229940088679 drug related substance Drugs 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000007972 injectable composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000002002 slurry Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36456702P | 2002-03-15 | 2002-03-15 | |
| US41798702P | 2002-10-11 | 2002-10-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY148518A true MY148518A (en) | 2013-04-30 |
Family
ID=28045416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20030900A MY148518A (en) | 2002-03-15 | 2003-03-14 | Crystalline parecoxib sodium |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030232871A1 (https=) |
| EP (1) | EP1485362A1 (https=) |
| JP (1) | JP2005529084A (https=) |
| KR (1) | KR100763045B1 (https=) |
| CN (1) | CN1642926A (https=) |
| AR (1) | AR038985A1 (https=) |
| AU (1) | AU2003220180A1 (https=) |
| BR (1) | BR0308431A (https=) |
| CA (1) | CA2478500A1 (https=) |
| CO (1) | CO5631437A2 (https=) |
| IL (1) | IL163780A0 (https=) |
| MX (1) | MXPA04008932A (https=) |
| MY (1) | MY148518A (https=) |
| NZ (1) | NZ535951A (https=) |
| PL (1) | PL372880A1 (https=) |
| RU (1) | RU2300529C2 (https=) |
| TW (1) | TW200400949A (https=) |
| WO (1) | WO2003078408A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004087682A1 (en) * | 2003-04-04 | 2004-10-14 | Hetero Drugs Limited | Novel crystalline forms of parecoxib sodium |
| US7268109B2 (en) | 2003-10-02 | 2007-09-11 | Elan Pharmaceuticals, Inc. | Method for reducing pain |
| WO2005065684A1 (en) * | 2003-12-24 | 2005-07-21 | Pharmacia Corporation | Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever |
| ITMI20040019A1 (it) * | 2004-01-12 | 2004-04-12 | Univ Bari | Derivati isossazolici e loro impiego come inibitori della ciclossigenasi |
| US7796785B2 (en) * | 2005-03-03 | 2010-09-14 | Fujifilm Corporation | Image extracting apparatus, image extracting method, and image extracting program |
| US20080108664A1 (en) | 2005-12-23 | 2008-05-08 | Liu Belle B | Solid-state form of AMG 706 and pharmaceutical compositions thereof |
| US7989450B2 (en) | 2008-01-11 | 2011-08-02 | Universita' Degli Studi Di Bari | Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| GB0919757D0 (en) * | 2009-11-12 | 2009-12-30 | Johnson Matthey Plc | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| US8299295B2 (en) | 2009-10-15 | 2012-10-30 | Johnson Matthey Public Limited Company | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| CN105726496B (zh) * | 2014-12-12 | 2019-05-28 | 湖南科伦药物研究有限公司 | 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品 |
| CN105125506A (zh) * | 2015-08-18 | 2015-12-09 | 上海秀新臣邦医药科技有限公司 | 一种注射用帕瑞昔布钠及其制备方法 |
| CN106580893A (zh) * | 2016-12-26 | 2017-04-26 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠冻干粉针制剂 |
| CN106692079A (zh) * | 2016-12-26 | 2017-05-24 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠长效冻干粉针制剂 |
| CN117003769B (zh) * | 2023-07-11 | 2024-11-22 | 中国科学院宁波材料技术与工程研究所 | 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK285353B6 (sk) * | 1996-04-12 | 2006-11-03 | G. D. Searle & Co. | Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia |
| CZ298022B6 (cs) * | 1996-10-15 | 2007-05-30 | G. D. Searle & Co. | Použití inhibitoru cyklooxygenázy-2 pro výrobu léciva pro lécení a prevenci neoplazie |
| MY137736A (en) * | 2001-04-03 | 2009-03-31 | Pharmacia Corp | Reconstitutable parenteral composition |
| WO2003029230A1 (en) * | 2001-10-02 | 2003-04-10 | Pharmacia Corporation | Method for preparing benzenesulfonyl compounds |
-
2003
- 2003-03-12 US US10/387,173 patent/US20030232871A1/en not_active Abandoned
- 2003-03-12 NZ NZ535951A patent/NZ535951A/en unknown
- 2003-03-12 AU AU2003220180A patent/AU2003220180A1/en not_active Abandoned
- 2003-03-12 KR KR1020047014454A patent/KR100763045B1/ko not_active Expired - Fee Related
- 2003-03-12 IL IL16378003A patent/IL163780A0/xx unknown
- 2003-03-12 EP EP03716476A patent/EP1485362A1/en not_active Withdrawn
- 2003-03-12 CA CA002478500A patent/CA2478500A1/en not_active Abandoned
- 2003-03-12 BR BR0308431-0A patent/BR0308431A/pt not_active IP Right Cessation
- 2003-03-12 PL PL03372880A patent/PL372880A1/xx not_active Application Discontinuation
- 2003-03-12 JP JP2003576414A patent/JP2005529084A/ja active Pending
- 2003-03-12 WO PCT/US2003/007484 patent/WO2003078408A1/en not_active Ceased
- 2003-03-12 RU RU2004127585/04A patent/RU2300529C2/ru not_active IP Right Cessation
- 2003-03-12 CN CNA038060884A patent/CN1642926A/zh active Pending
- 2003-03-12 MX MXPA04008932A patent/MXPA04008932A/es unknown
- 2003-03-14 TW TW092105693A patent/TW200400949A/zh unknown
- 2003-03-14 MY MYPI20030900A patent/MY148518A/en unknown
- 2003-03-14 AR ARP030100915A patent/AR038985A1/es unknown
-
2004
- 2004-09-10 CO CO04090186A patent/CO5631437A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005529084A (ja) | 2005-09-29 |
| RU2004127585A (ru) | 2005-04-10 |
| TW200400949A (en) | 2004-01-16 |
| KR100763045B1 (ko) | 2007-10-04 |
| KR20040095288A (ko) | 2004-11-12 |
| IL163780A0 (en) | 2005-12-18 |
| EP1485362A1 (en) | 2004-12-15 |
| US20030232871A1 (en) | 2003-12-18 |
| NZ535951A (en) | 2006-02-24 |
| AU2003220180A1 (en) | 2003-09-29 |
| CO5631437A2 (es) | 2006-04-28 |
| CA2478500A1 (en) | 2003-09-25 |
| CN1642926A (zh) | 2005-07-20 |
| MXPA04008932A (es) | 2004-11-26 |
| BR0308431A (pt) | 2005-01-18 |
| PL372880A1 (en) | 2005-08-08 |
| WO2003078408A1 (en) | 2003-09-25 |
| RU2300529C2 (ru) | 2007-06-10 |
| AR038985A1 (es) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148518A (en) | Crystalline parecoxib sodium | |
| JO2475B1 (en) | Glucokinase stimulants | |
| MXPA02012763A (es) | Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus. | |
| MXPA03006841A (es) | 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico. | |
| IL198783A0 (en) | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo | |
| TW200626558A (en) | Indazolone derivatives | |
| MY119403A (en) | Novel compounds with analgesic effect. | |
| TW200738241A (en) | Pyridazine derivatives | |
| MXPA02005173A (es) | Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea. | |
| NO20053498L (no) | Derivater av aryl-quinaolin/aryl-2-amino-fenylmetanon som fremmer frigivelse av paratyroidhormon | |
| GB2352972A (en) | Use of dexmedetomidine for icu sedation | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| EA200100540A1 (ru) | Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину | |
| MX2010003594A (es) | Formas cristalinas de sal sodica de dmxaa. | |
| MX2007003105A (es) | Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i. | |
| IL141232A0 (en) | Use of camptothecin derivatives, with reduced gastrointestinal toxicity | |
| WO2001085144A3 (en) | Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| AU8186701A (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents | |
| YU20902A (sh) | Primena karbinola supstituisanih sa 2-imidazolilom za izradu medikamenta za lečenje ili profilaksu oboljenja izazvanih ishemičkim stanjima | |
| JPS5665079A (en) | Stabilization of ground | |
| TH63282A (th) | พาเรโคซิบโซเดียมที่เป็นผลึก | |
| TW200744616A (en) | Drugs for treating cerebral infarction | |
| ZA9427B (en) | Use of riluzole for promoting restoration following radiation | |
| YU89903A (sh) | Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa |